In-Depth Focus From CHEST 2019: Asthma

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

Publish Date May 9, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

Benralizumab Associated With Improvements in SGRQ Scores in Asthma

By

Pulmonology Advisor Contributing Writer

Publish Date November 22, 2019

In patients with asthma, benralizumab is associated with substantial improvements in total scores on the St. George’s Respiratory Questionnaire.

Oral Montelukast Not Effective as Adjuvant in Pediatric Acute Moderate Asthma

By

Florence Chaverneff, Ph.D.

Publish Date November 1, 2019

Children with an acute exacerbation of asthma were randomly assigned to receive a single tablet of montelukast or placebo.

Despite Risks, Long-Term Oral Corticosteroid Use Still Common in Asthma

By

Pulmonology Advisor Contributing Writer

Publish Date November 1, 2019

Despite the potential for adverse events, long-term use of oral corticosteroid medications is common among patients with poor asthma control.

Asthma Linked to Reduced Mortality in Adults Admitted for Myocardial Infarction

By

Britt Gambino

Publish Date November 1, 2019

Asthma appeared to be associated with lower mortality in patients admitted to the hospital with myocardial infarction.

Dupilumab Reduced Severe Exacerbations in Oral Corticosteroid-Dependent Asthma

By

Lea Eslava-Kim, PharmD

Publish Date November 1, 2019

Dupilumab significantly reduced severe asthma exacerbations in patients with oral corticosteroid-dependent severe asthma with and without early improvements in lung function.

Mepolizumab Effective in Asthma Regardless of Background Controller Therapies

By

Pulmonology Advisor Contributing Writer

Publish Date November 1, 2019

Irrespective of the type and number of background controller therapies, mepolizumab consistently reduced the annual rate of exacerbations in severe eosinophilic asthma compared with placebo.

Long-Term Asthma Control in Children: ICS With and Without LABA

By

Pulmonology Advisor Contributing Writer

Publish Date November 1, 2019

Better asthma control in children can be achieved by either increasing inhaled corticosteroid dose or by switching to a combination of inhaled corticosteroid plus long-acting beta agonist with similar treatment outcomes.